ExoPTEN, which is advancing towards first-in-human trials. The study demonstrated that ExoPTEN significantly enhances motor function recovery and improves blood flow at spinal cord injury sites, ...

The university’s materials engineering collegium researcher developed methods to segregate nanotubes based on their chirality ...

Japan’s Shionogi (TYO: 4507) yesterday delivered a late-breaking scientific oral presentation at the Conference of ...

Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically relevant approach to determine clonal tumor mutation ...

For more information on the Phase 1b clinical trial, visit: https://clinicaltrials.gov/study/NCT06732180 ...

INVINCIBLE-3 Study, and 25 patients have been screened Eight Swiss sites are activated in the INVINCIBLE-4 Study, and several ...

The agreement on the Council's negotiating mandate allows its presidency to start negotiations with the European Parliament ...